[1]
“Use of bortezomib in the treatment of refractory autoimmune hemolytic anemia in a patient with systemic lupus erythematosus”, Acervo Saúde, vol. 25, no. 8, p. e20869, Aug. 2025, doi: 10.25248/reas.e20869.2025.